| 000 | 01699 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516115025.0 | ||
| 264 | 0 | _c20130610 | |
| 008 | 201306s 0 0 eng d | ||
| 022 | _a1098-6596 | ||
| 024 | 7 |
_a10.1128/AAC.01157-12 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEspinal, P | |
| 245 | 0 | 0 |
_aFirst report of an OXA-23 carbapenemase-producing Acinetobacter baumannii clinical isolate related to Tn2006 in Spain. _h[electronic resource] |
| 260 |
_bAntimicrobial agents and chemotherapy _cJan 2013 |
||
| 300 |
_a589-91 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAcinetobacter Infections _xdrug therapy |
| 650 | 0 | 4 |
_aAcinetobacter baumannii _xdrug effects |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
| 650 | 0 | 4 | _aBacterial Typing Techniques |
| 650 | 0 | 4 |
_aCarbapenems _xpharmacology |
| 650 | 0 | 4 | _aChromosomes, Bacterial |
| 650 | 0 | 4 | _aDNA Transposable Elements |
| 650 | 0 | 4 | _aElectrophoresis, Gel, Pulsed-Field |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aSpain |
| 650 | 0 | 4 |
_abeta-Lactam Resistance _xgenetics |
| 650 | 0 | 4 |
_abeta-Lactamases _xgenetics |
| 700 | 1 | _aMacià, M D | |
| 700 | 1 | _aRoca, I | |
| 700 | 1 | _aGato, E | |
| 700 | 1 | _aRuíz, E | |
| 700 | 1 | _aFernández-Cuenca, F | |
| 700 | 1 | _aOliver, A | |
| 700 | 1 | _aRodríguez-Baño, J | |
| 700 | 1 | _aBou, G | |
| 700 | 1 | _aTomás, M | |
| 700 | 1 | _aVila, J | |
| 773 | 0 |
_tAntimicrobial agents and chemotherapy _gvol. 57 _gno. 1 _gp. 589-91 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/AAC.01157-12 _zAvailable from publisher's website |
| 999 |
_c22187279 _d22187279 |
||